Class II · Moderate riskTerminated Initiated Aug 24, 2020 (6 years ago)
Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.
What was recalled
Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4175-73, b) 200 mL bottle when mixed, NDC 0093-4175-74, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.
Recalling firm
Teva Pharmaceuticals USA
NDC code
0093-4175-73
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0012-2021
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Labeling: Not Elsewhere Classified: Back Label states Each contains: cephalexin monohydrate, USP equivalent to 5g' on the back label instead of…